Key Trends Shaping the Future Automated Compounding Devices Market From 2025-2034: Innovations In IV Robotic Technology For Hospital Pharmacies

How Are the key drivers contributing to the expansion of the automated compounding devices market?
The growth of the automated compounding devices market looks set to be driven by the surge in the number of personalized medicines. Personalized medicine, a medical method that customizes healthcare decisions, practices, interventions, and treatments based on each patient's specific characteristics, is on the rise. This surge can be attributed to an enhanced understanding of genetics, patient-specific data, and regulatory support. Automated compounding devices perform a vital role in personalized medicine as they allow custom drug formulations for individual patients to be prepared with precision and accuracy. These machines automate the procedure of compiling different pharmaceutical ingredients in precise proportions, a critical task in forging personalized treatments. For example, the Personalized Medicine Coalition, a non-profit organization from the US, reported in February 2024 that the FDA approved 16 new personalized therapies for people with rare diseases in 2023, a significant increase from the six approved in 2022. Consequently, the surge in personalized medicines is stimulating the growth of the automated compounding devices market.

Get Your Automated Compounding Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

What growth opportunities are expected to drive the automated compounding devices market's CAGR through 2034?
The market size of automated compounding devices has experienced robust growth in the past few years. The market value is expected to rise from $2.36 billion in 2024 to $2.53 billion in 2025, signalling a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the historic period include an increase in chronic diseases, an aging population, expansion in healthcare infrastructure, regulatory mandates, and a rise in medication errors.

In the upcoming years, the market size of automated compounding devices is predicted to witness robust growth. It is expected to rise to a significant $3.34 billion by 2029, boasting a compound annual growth rate (CAGR) of 7.2%. Factors contributing to the predicted growth in this forecast period include a surge in cancer cases globally, expansion of healthcare services, enhanced focus on patient safety, regulatory backing, and an increased emphasis on sustainability. The prominent trends expected during this forecast period encompass telemedicine, remote healthcare, progress in artificial intelligence, the digitization of healthcare, and monitoring in real-time.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

What are the emerging trends shaping the future of the automated compounding devices market?
Leading firms within the automated compounding device sector are honing their focus on reducing medication mistakes and bolstering patient safety through the adoption of cutting-edge solutions, such as robotic compounding technology. This technology allows such companies to gain increased customer trust, satisfy regulatory requirements, and offer a competitive edge. The robotic compounding tech automates the meticulous process associated with the preparation and mixing of medicinal compounds withing advanced robotic systems. This way, it optimizes precision, effectiveness, and the safety of medication preparation. As an example, Omnicell Inc., a healthcare technology firm based in the U.S, launched a novel automated compounding device known as the IVX Station in March 2022. This revolutionary solution is set to widen the accessibility of IV robotic technology in the larger market, consequently improving patient safety, accuracy, cost-efficiency, supply chain management, and regulatory compliance. Furthermore, the IVX Station boasts a throughput that's three times faster than existing IV robotic systems, a highly-dependable design to limit downtime, and maintains a small footprint perfect for pharmacy operations.

Which growth-oriented segments of the automated compounding devices market are leading the industry's development?
The automated compounding devices market covered in this report is segmented -

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)
2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18231

What regions are leading the charge in the automated compounding devices market?
North America was the largest region in the automated compounding devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the automated compounding devices market?
Major companies operating in the automated compounding devices market are McKesson Corporation, Amerisource Bergen Corporation, Medtronic PLC, Becton Dickinson and Company, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, Grifols International S.A., Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Cantel Medical Corp., Fagron N.V., Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group S.p.A., ARxIUM Inc., Codonics Inc., Apexus Inc., Equashield LLC, Yuyama Mfg Co. Ltd., Shanghai Weibond Technology Co. Ltd., Quirem Medical B.V

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=18231&type=smp

What Is Covered In The Automated Compounding Devices Global Market Report?

•Market Size Forecast: Examine the automated compounding devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the automated compounding devices market for a structured understanding.
•Key Players Overview: Analyze major players in the automated compounding devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the automated compounding devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the automated compounding devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the automated compounding devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the automated compounding devices market.
•Competitive Landscape: Review strategic developments in the automated compounding devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.